A Study Evaluating the Safety, Tolerability, and Pharmacokinetics of GDC-0425 Administered With and Without Gemcitabine in Patients With Refractory Solid Tumors or Lymphoma
This study is currently recruiting participants.
Verified November 2012 by Genentech
Study NCT01359696
Information provided by Genentech
First Received on May 23, 2011.
Last Updated on November 2, 2012
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
